Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S325.
doi: 10.21037/atm.2019.09.130.

Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach

Affiliations
Editorial

Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach

Arta Karruli et al. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: E Durante-Mangoni received grant support and speaker’s honoraria from Pfizer, MSD, Angelini, Bio-Merieux, Abbvie, Sanofi-Aventis, Medtronic, and DiaSorin. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Effective interventions in prevention of CRKP spread. CRKP, carbapenem-resistant Klebsiella pneumoniae.

Comment on

References

    1. Tian L, Tan R, Chen Y, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control 2016;5:48. 10.1186/s13756-016-0145-0 - DOI - PMC - PubMed
    1. Bassetti M, Poulakou G, Ruppe E, et al. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med 2017;43:1464-75. 10.1007/s00134-017-4878-x - DOI - PubMed
    1. Li M, Wang X, Wang J, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrob Resist Infect Control 2019;8:8. 10.1186/s13756-018-0453-7 - DOI - PMC - PubMed
    1. Borer A, Eskira S, Nativ R, et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel. Infect Control Hosp Epidemiol 2011;32:1158-65. 10.1086/662620 - DOI - PubMed
    1. Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect 2019;25:943-50. 10.1016/j.cmi.2019.04.013 - DOI - PubMed